Neuren Pharmaceuticals
NEU.AX
#5122
Rank
HK$14.63 B
Marketcap
HK$115.44
Share price
-0.15%
Change (1 day)
14.66%
Change (1 year)

Earnings for Neuren Pharmaceuticals (NEU.AX)

Earnings in 2025: HK$0.20 Billion

According to Neuren Pharmaceuticals's latest financial reports the company's current earnings are HK$43.29 Million. In 2025 the company made an earning of HK$0.20 Billion a decrease over its 2024 earnings that were of HK$0.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neuren Pharmaceuticals from 2002 to 2025

Annual earnings

Year Earnings Change
2025HK$0.20 B-77.09%
2024HK$0.89 B-18.58%
2023HK$1.09 B111519.63%
2022HK$0.98 M-102.22%
2021-HK$44.33 Million-20.06%
2020-HK$55.46 Million-6.65%
2019-HK$59.41 Million-449.8%
2018HK$16.98 M-213.69%
2017-HK$14.94 Million-80.94%
2016-HK$78.37 Million-3.07%
2015-HK$80.85 Million51.42%
2014-HK$53.4 Million-32.7%
2013-HK$79.33 Million87.47%
2012-HK$42.32 Million10.96%
2011-HK$38.14 Million-4.11%
2010-HK$39.77 Million21025.61%
2009-HK$0.19 Million-99.78%
2008-HK$85.01 Million1.99%
2007-HK$83.35 Million33.24%
2006-HK$62.56 Million31.45%
2005-HK$47.59 Million37.67%
2004-HK$34.57 Million4.98%
2003-HK$32.93 Million36.5%
2002-HK$24.13 Million